Navigation Links
Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
Date:4/28/2011

ooking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.  Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 as filed with the SEC on February 9, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequ
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ULURU Inc. Announces Commercial Exhibit and Scientific Presentations at the SAWC/WHS National Wound Symposium
2. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
3. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
4. Dendreon Announces Webcast Presentations at Upcoming Conferences
5. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
6. Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL)
7. Thoratec Announces Presentations at Upcoming Investor Conferences
8. Dehaier Medical Announces March Investor Presentations
9. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
10. Gen-Probe to Webcast Three Upcoming Investor Presentations
11. Regeneron Announces March 2011 Investor Conference Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... CLEVELAND , Jan. 14, 2014 NineSigma ... will hold its Innovation Leadership Summit , May ... in Cleveland Ohio . ... innovators and organizations committed to breakthrough achievements through open ...
(Date:1/14/2014)... York , January 14, 2014 ... System Transfer Devices (CSTD) for hazardous drugs, today announced that ... the fourth straight year.   Equashield,s ... pharmacy technicians, pharmacists, nurses and other medical professionals ...
(Date:1/14/2014)... Therapeutics , a late-stage gene therapy company, has reached its patient ... study for inherited retinal dystrophies caused by mutations in the ... presenting this and other corporate updates today, at the 32nd Annual ... Marrazzo said Spark was able to achieve its recruitment goal a ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
... For the second consecutive year, the Exergen temporal artery ... stock the product, according to Nielsen and Information Resources ... including national brands and private label products, were compared. ... share has risen to 20 percent of all thermometers ...
... 2011 JLL Partners Inc. is pleased to announce ... PharmaNet Development Group, Inc. ("PharmaNet") to inVentiv Health, Inc. ... and inVentiv Health, Inc. is a leading global provider ... pharmaceutical and healthcare industries. Ramsey A. Frank, ...
Cached Medicine Technology:JLL Partners Sells PharmaNet 2
(Date:7/10/2014)... to 70% of Parkinson,s disease (PD) patients experience ... life. Some patients have disturbed sleep/wake patterns such ... other patients may be subject to sudden and ... patients may exhibit REM-sleep behavior disorder (RBD), characterized ... before motor symptoms appear. A review in the ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... research review identifying the clinical indicators most strongly associated ... process of developing evidence-based guidelines for concussion diagnosis, prognosis, ... Neurosurgery , official journal of the ... is published by Lippincott Williams & Wilkins , ... , Based on analysis of the best available ...
(Date:7/10/2014)... Harbor, NY For decades, health-conscious people around the ... in antioxidants, figuring this was one of the paths ... , Yet clinical trials of antioxidant supplements have repeatedly ... to reduce their cancer risk. Virtually all such ... cancer. In fact, in several trials antioxidant supplementation ...
(Date:7/10/2014)... Biomedical Research Institute (IDIBELL) and the Catalan Institute of ... new therapeutic combination to combat resistant sarcomas. The clinical ... stabilize the growth of these tumors have been published ... ., Sarcomas , Sarcomas are a rare type ... It can affect from children to older ages. It ...
Breaking Medicine News(10 mins):Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:How antioxidants can accelerate cancers, and why they don't protect against them 2Health News:New therapeutic combination to slow resistant sarcomas 2
... led by an Indian American scientist have genetically engineered ... // ,Cotton fibre continues to be a globally ... source of protein, but the presence of the toxic ... ,To remove gossypol from cottonseeds, Keerti Rathore and ...
... an AIDS disaster and should get a control over the ... out of control //warned Ashok Alexander, the director of the ... official. ,According to Ashok Alexander who directs the $258-million ... said that the rising prevalence of HIV in more than ...
... South Kazakhstan has reached 80 with the recent death //of ... officials and non-governmental groups. It is believed that the five-year-old ... death. ,Chief physician of the regional HIV/ AIDS ... on Monday that a child infected with HIV was registered ...
... Between 2001 and 2006, the number of AIDS cases reported ... a formidable 61. //The increasing use of heroin has raised ... the spread of AIDS in the nation. , ,Anti-narcotics ... in Kabul has gone up from 7,000 in 2003, to ...
... by the Canadian MedicAlert Foundation.It now waives the fees ... special bracelet or necklet. , Children up ... allergies, asthma and diabetes in participating elementary schools will ... to this foundation about five per cent of children ...
... Researchers from Toronto, Canada have found that only a small ... not all the cells as believed earlier. // ,This ... have been found to be the source of the disease. ... This finding supports the view - stem cells may be ...
Cached Medicine News:Health News:India warned of Impending AIDS Disaster 2Health News:Cancer Stem Cells Alone spread Cancer 2
... part in our daily lives. But degenerative ... cause severe handicaps. A decisive consideration in ... to produce a reconstructed joint function that ... possible.,The cementless RM Finger System has proven ...
... The Low Profile Leg Holder provides precise control ... leg rotation, and maximum exposure of the proximal ... Profile Leg Holder can be used on both ... to different heights.,The Low Profile Leg Holder can ...
... knee during surgery. Slotted base allows the ... knee surgery. Slots are also designed to allow ... can be sterilized by either gas or steam ... can be clamped over the sterile drape to ...
... The True/Flex Upper Extremity Intramedullary Rod System ... alternative to conventional methods of rodding and ... micromotion at the fracture site and enhanced ... rods to be easily inserted into the ...
Medicine Products: